Strategic Objectives


Strategic Objectives

Operationalize a Fully Functional Regulatory System

“BoMRA is targeting to be at WHO maturity level 3 (ML3) where 8 core regulatory functions will be operational and meet the criteria and standards set. The Authority will conduct annual WHO Global Benchmarking (GBT) self-assessments and final WHO assessments to reach ML3.BoMRA will facilitate the review of the Medicines and Related Substance Act to strengthen its scope, definitions, structures, and instruments to enable its regulatory effectiveness.”

Reduced incidences of substandard and falsified medicines and related substances.​​

“The Botswana Medicines Regulatory Authority will establish a Pharmacovigilance system to track and report on Adverse Drug Reactions and take any remedial action to protect human and animal health. Improved awareness and Public Trust in the Improved awareness and Public Trust in the Medical Products and Cosmetics regulatory system.”

Scale up current institutional capacity to deliver the full spectrum of regulatory services. ​​

We Want Your Feedback

Your feedback improves our general service
delivery, we strive on excellence and good
customer service.